BIO RSI

What is BIO?

Bio-Rad Laboratories started in a Quonset hut in Berkeley, California, back in 1952. Founders David and Alice Schwartz launched the company to provide specialized chemicals for research, and it has since evolved into a massive player in the life science and clinical diagnostics markets. They basically provide the picks and shovels for the modern biotech gold rush.

The business model is split into two primary segments. The Life Science wing develops and manufactures a range of instruments and reagents used in biological research. Their Droplet Digital PCR technology is particularly famous, setting the standard for absolute quantification of DNA. They also excel in chromatography and protein analysis. On the other side, Clinical Diagnostics provides test systems and kits for clinical labs. This includes everything from blood typing and autoimmune disease testing to monitoring diabetes via hemoglobin A1c levels.

Historically, Bio-Rad has grown through smart acquisitions and a razor-and-blade strategy. They sell the high-tech equipment once and then enjoy a steady stream of revenue from the proprietary consumables used with those machines. Financially, they are in a unique spot because they own a massive chunk of Sartorius AG, which often impacts their reported net income significantly due to equity shifts. However, their core operations remain robust with strong margins and consistent cash flows.

Looking toward 2026, Bio-Rad’s strategic focus is likely to center on bioprocessing and expanding their digital PCR footprint into more clinical applications. They are also investing heavily in automation and integrating AI to speed up diagnostic workflows. As the healthcare industry moves toward personalized medicine, Bio-Rad is positioning itself as an essential partner for high-sensitivity testing. They have managed to maintain a family-controlled atmosphere while competing on a global scale, which gives them a long-term stability that many investors appreciate in a volatile market.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For BIO, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, Bio-Rad Laboratories, Inc.Class A is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding BIO RSI Signals

• Oversold (RSI below 30): When BIO RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates BIO may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When BIO price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for BIO

This page displays both daily and weekly RSI for BIO. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand Bio-Rad Laboratories, Inc.Class A's momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when BIO RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how Bio-Rad Laboratories, Inc.Class A has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.